EFG Capital International’s Thermo Fisher Scientific TMO Stock Holding History

EFG Capital International’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.06M	Buy	+9,695	New	+$5.23M	1.17%	26

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

EFG Capital International's TMO Position: Q2 2023 in Review

EFG Capital International opened a new position in Thermo Fisher Scientific (TMO) in Q2 2023: 9,695 shares worth $5.06M. The stake represents 1.17% of the portfolio and ranks #26 among its holdings.

2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

EFG Capital International held 9,695 shares of Thermo Fisher Scientific worth $5.06M as of Q2 2023.
Thermo Fisher Scientific was a new EFG Capital International position in Q2 2023.
Thermo Fisher Scientific made up 1.17% of EFG Capital International's portfolio in Q2 2023, its #26 holding.
2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on EFG Capital International's 13F filing for Q2 2023, filed 2 Aug 2023.